Holdings of Spruce Street Capital LP
25 declared positions · as of Mar 31, 2026
Original filing · Ten largest lines: 68.9 % of the equity sleeve
Sector breakdown
- Unattributed 100.0 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- US 100.0 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | US | 25 | 363M $ | 100.00 % |
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Relmada Therapeutics Inc | 6,262,114 | 43M $ | |
| 2 | LB Pharmaceuticals Inc | 1,376,159 | 33.6M $ | |
| 3 | Dianthus Therapeutics Inc | 373,274 | 31.3M $ | |
| 4 | Relay Therapeutics Inc | 2,984,125 | 29.7M $ | |
| 5 | Alto Neuroscience Inc | 1,325,210 | 29.1M $ | |
| 6 | CENTESSA PHARMACEUTICALS PLC | 489,849 | 19.5M $ | |
| 7 | Savara Inc | 3,383,175 | 18.5M $ | |
| 8 | KalVista Pharmaceuticals Inc | 897,681 | 18.1M $ | |
| 9 | Vaxcyte Inc | 245,709 | 14.3M $ | |
| 10 | Enliven Therapeutics Inc | 329,006 | 12.9M $ | |
| 11 | Surrozen Inc | 432,040 | 12.6M $ | |
| 12 | Enanta Pharmaceuticals Inc | 932,598 | 11.8M $ | |
| 13 | Perspective Therapeutics Inc | 2,627,107 | 11M $ | |
| 14 | Minerva Neurosciences Inc | 1,655,500 | 10M $ | |
| 15 | Century Therapeutics Inc | 4,059,054 | 9.2M $ | |
| 16 | Alumis Inc | 392,574 | 8.6M $ | |
| 17 | SAB Biotherapeutics Inc | 2,198,502 | 8.4M $ | |
| 18 | Erasca Inc | 422,543 | 6.8M $ | |
| 19 | Inhibikase Therapeutics Inc | 3,581,603 | 6M $ | |
| 20 | Maze Therapeutics Inc | 200,000 | 6M $ | |
| 21 | AN2 Therapeutics Inc | 1,661,073 | 5.6M $ | |
| 22 | Lexeo Therapeutics Inc | 928,593 | 5.3M $ | |
| 23 | Alector Inc | 2,101,068 | 4.5M $ | |
| 24 | LeonaBio Inc | 393,701 | 3.8M $ | |
| 25 | Corvus Pharmaceuticals Inc | 231,585 | 3.4M $ |